Hypertension

Cardiovascular Health Change Patterns After Multifaceted Antihypertensive Intervention and Cardiovascular Outcomes: A Post Hoc Analysis of CRHCP Trial

J Am Coll CardiolPublished Secondary analysis of the CRHC randomised trial

Authors' conclusion

In this large community-based randomized trial, a scalable intervention delivered by nonphysician providers reduced cardiovascular risk, with the benefit primarily driven by BP, alongside modest contributions from behavioral and metabolic domains.

Study context

Population
Rural Chinese participants with hypertension in the China Rural Hypertension Control Project
Participants
26,700 participants
Comparison
Change patterns in cardiovascular health (CVH) (LS7 domains) after intensive blood pressure (BP) intervention and subsequent CV outcomes
Primary endpoint
Association of domain-specific CVH change patterns (BP, metabolic, behavioral) with subsequent CV outcomes
Follow-up
36-48 months
Methodological detailspost hoc analysis, community-based
  • Post hoc analysis
  • Community-based

Primary result

As reported in the abstract

CV outcomes by CVH change pattern
Hazard ratio (95% CI)
Improved CVH
0.71(0.54–0.89)
BP improvement plus behavioral or metabolic gains
0.57(0.30–0.84)
BP improvement alone
0.76(0.55–0.98)

Further findings

LS7 score · 36 months

ComparisonNet difference (95% CI)
Intervention0.52 (0.38–0.66)

Mediation of CV risk reduction

BP share of effect
67.5%
Behavioral share of effect
8.0%
Metabolic contribution minimal

BP and other LS7 components over time

Sustained separation in BP between groups; only modest, less-differentiated changes in other components

Original publication

Cardiovascular Health Change Patterns After Multifaceted Antihypertensive Intervention and Cardiovascular Outcomes: A Post Hoc Analysis of CRHCP Trial. J Am Coll Cardiol. Published 26 June 2026. doi:10.1016/j.jacc.2026.05.035

Summarised from the published abstract; every number is checked against it

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.